R&D Granulation Lines
Granulation lines for research and development, takes the process from dispensed raw materials to finished tablet. Our systems clearly demonstrates the flexibility that can be achieved throughout the process – including high shear granulation, pelletizing and blending, etc.
All technologies can be brought together in an integrated process system that mimics the hundreds of large-scale plants provided by GEA globally. It epitomizes the approach of ensuring customers receive the same technology from the laboratory through to production, using the same containment and process technologies to ensure seamless scale-up and the most flexible blend of process capabilities.
Products
Weergegeven 4 van 8
AirConnect Fluid Bed Processor & Coater
Committed to providing flexible, modular equipment to support research and development in the pharmaceutical industry, the multipurpose AirConnect from GEA delivers a range of fluid bed processing solutions for small-scale applications.
ConsiGma® 1 - R&D Granulation and Drying
The ConsiGma® 1 offers standalone continuous twin-screw granulation and drying for small-scale R&D operations. It allows users to develop the process and achieve high granule quality on a compact unit.
ConsiGma® Compact Feeder (CF) Test Rig
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
ConsiGma® Conductor
An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
Downloads
GEA-inzichten
GEA opens new technology center, strengthening its position in the growing pharmaceutical applications market
Together with Mona Neubaur, Minister of Economic Affairs of the German state of North Rhine-Westphalia, GEA CEO Stefan Klebert has opened a new technology center for pharmaceutical freeze-drying systems in Elsdorf, Germany. GEA employs approximately 260 people at the facility, which combines research and development with production and service under one roof.
